Cell MedX Corp. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €224.55K
    R&D expenses
    -€1.35K
    EBITDA
    -€150.79K
    D&A
    €72.48K
    EBIT
    -€164.39K
    Interest expenses
    €22.11K
    EBT
    -€406.58K
    Tax expenses
    €0.00
    Net income
    -€406.58K

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €268.74K
    Changes in working capital
    €54.81K
    Operating cash flow
    -€85.87K
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €2.87
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    -€3.42K
    Other financing cash flow
    €48.43K
    Net financing cash flow
    €66.12K
    Foreign exchange effects
    -€466.96
    Net change in cash
    -€51.46K
    Cash at end of period
    €5.75K
    Free cash flow
    -€85.87K

    Balance sheet

    Cash and cash equivalents
    €5.75K
    Cash and short-term investments
    €5.75K
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €0.00
    Total current assets
    €5.75K
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €14.74K
    Accounts payable
    €267.86K
    Short-term debt
    €0.00
    Other current liabilities
    -€267.86K
    Total current liabilities
    €267.86K
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €668.93K
    Total non-current liabilities
    €668.93K
    Total liabilities
    €936.78K
    Common stock
    €17.07K
    Retained earnings
    -€9.17M
    Other equity
    €145.63K
    Total equity
    €0.00
    Total liabilities and shareholders' equity
    €14.74K

    Company information

    Market capitalization
    €107.75M
    Employees
    0
    Enterprise Value
    €126.32M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    0.0%
    ROA
    -2,758.2% Much worse than peer group: -175.6%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -0.1%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    €0.00

    Notifications